Deiodinases, selenocysteine-containing enzymes, are responsible for the conversion and metabolism of the thyroid hormones. Deiodinase types 1 and 2 convert T 4 to T 3 , whereas deiodinase type 3 (D3) is responsible for metabolizing T 3 to the relatively inactive diiodothyronine (T 2 ) (for review see Ref. 1). In fish, thyroid hormone is mainly synthesized as T 4 and deiodinases in the peripheral tissues such as the liver are responsible for conversion to T 3 and subsequent metabolism (1).
T HYROID HORMONES (T 4 and T 3 ) act via specific
thyroid hormone receptors (TRs) and are vital mediators of normal growth and development in vertebrates. Deiodinases, selenocysteine-containing enzymes, are responsible for the conversion and metabolism of the thyroid hormones. Deiodinase types 1 and 2 convert T 4 to T 3 , whereas deiodinase type 3 (D3) is responsible for metabolizing T 3 to the relatively inactive diiodothyronine (T 2 ) (for review see Ref. 1) . In fish, thyroid hormone is mainly synthesized as T 4 and deiodinases in the peripheral tissues such as the liver are responsible for conversion to T 3 and subsequent metabolism (1) .
TRs belong to a large superfamily of nuclear receptors (2, 3) . Nuclear receptor structure can be categorized into six domains, including the DNA-binding domain, and the ligand-binding domain (LBD). TRs typically localize to specific thyroid response elements in the DNA as heterodimers with a retinoid-X receptor, although heterodimers with peroxisomal proliferator-activated receptors or other transcription factors, homodimers or even homotrimers are possible (4 -8) . In the absence of ligand, they actively repress gene transcription via corepressors which ultimately leads to the recruitment of histone deacetylase (HDAC) and the subsequent deacetylation of histone proteins (9, 10) . In the presence of ligand, corepressors are replaced with coactivators, leading to recruitment of histone acetyltransferases and eventual recruitment of RNA-polymerase and subsequent gene transcription.
In most vertebrates, two genes: THRA (NR1A1) and THRB (NR1A2) encode for TR␣ and TR␤, respectively (11, 12) . In mammals, alternative splicing and alternative promoter usage as well as an internal start codon leads to the generation of four functional receptors (TR␣-1, TR␤-1, TR␤-2, and TR␤-3), three N-terminal variants, a splice variant missing the hinge region, and a C-terminal splice variant TR␣-2 that fails to bind hormone (13) (14) (15) (16) (17) (18) (19) (20) . In nonmammalian vertebrates, N-terminal truncations have been described in the alligator (21) . We recently described four TR transcripts in goldfish: two complete receptors (TR␣-1, TR␤) and two receptors with C-terminal variation (TR␣-2 and TR␣ truncated) (22) . Goldfish TR␣-2 is believed to be a splice variant of TR␣-1 because it is identical in nucleotide sequence except for an out-of-frame deletion in the LBD. TR␣-truncated (TR␣-t) is very similar to TR␣-1 until the hinge region in which it loses homology and reaches a premature stop codon before the LBD.
Because it is likely that TR␣-t does not bind hormone, our main hypothesis was that TR␣-t modulates thyroid hormone activity. To test this hypothesis, we first established a thyroid hormone-responsive bioassay in goldfish. Based on its function in other species, we tested the postulate that T 3 induces hepatic D3. Using short interfering RNA (siRNA) to selectively target and knock down the goldfish TR subtypes, along with the induction of D3 as a bioassay, we tested our main hypothesis.
Materials and Methods Animals
Male and female goldfish (Carassius auratus), ranging from 8 to 12 cm in length, were killed in accordance with the principles and guidelines of the Canadian Council of Animal Care.
Primary hepatocyte culture
Goldfish livers of mixed sex were manually diced washed in buffer followed by treatment with collagenase, trypsin, and deoxyribonuclease at 28 C with gentle shaking for 30 -45 min and then filtered through a 40-m nylon sieve. Cells were washed and loaded onto a Percoll (GE Life Sciences, Piscataway, NJ) gradient (20 -40 -60% ) and spun at 1200 rpm for 30 -45 min. Hepatocytes were isolated, washed, and plated on 24-well plates at a density of 750,000 and incubated in 1 ml of phenol red free M199 with penicillin and streptomycin.
Cloning of goldfish D3
All primers used are listed in supplemental Table 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://endo.endojournals.org. RNA extraction, RT-PCR, and rapid amplification of 3Ј cDNA ends (RACE) was carried out as reported elsewhere (22) . 5ЈRACE was performed using the SMART kit by CLON-TECH (Palo Alto, CA). Sequences were aligned and analyzed using National Center for Biotechnology Information (Bethesda, MD) and Multalin (http://bioinfo.genopole-toulouse.prd.fr/multalin/) web pages.
In vivo regulation of D3 by T 3
Goldfish were injected ip with 0, 2.5, 25, and 250 ng of T 3 per fish. Controls were injected with vehicle dissolved saline. Semiquantitative RT-PCR was preformed as described previously (22, 23) . As an internal control, 18S rRNA was also amplified for each sample.
In vitro regulation of D3
Goldfish hepatocytes were treated with T 3 at doses of 0, 0.5, 5, and 50 ng/ml for 5 h. Doses of 0.5 and 5 ng/ml resemble physiologic plasma levels of T 3 reported in other studies (24, 25) . Control cells were treated with vehicle. Quantitative (real time) PCR (QPCR) was performed as described below. Separate experiments were carried out to determine the nature of the D3 induction by T 3 and the involvement of HDAC. Cells were treated with either T 3 (50 ng/ml), an inhibitor of protein translation (cycloheximide, 15 g/ml), an inhibitor of transcription (actinomycin-D, 10 m), an HDAC inhibitor [4-dimethylamino-N-(6-hydroxycarbamoylhexyl), benzamide, 1 m (Calbiochem, La Jolla, CA); analog of trichostatin A that potently inhibits histone deacetylases (26 -28) ], or both T 3 and an inhibitor. A dose of 1 m was chosen for the HDAC inhibitor because this is a 10-fold higher concentration than the IC 50 for maize and would likely result in a near compete HDAC inhibition in goldfish. Differentiation was induced and proliferation was inhibited in murine erythroleukemia cells at about 2 m. For the HDAC experiments, two controls were used, one treated with the vehicle for the HDAC inhibitor [dimethylsulfoxide (DMSO)] and the other treated with the vehicle for T 3 (NaOH).
RNA interference
siRNA specifically targeting each of the goldfish TR subtypes in addition to one siRNA, which would target all of the TR subtypes, were synthesized and purified (University of Calgary Core DNA Services) (supplemental Table 2 ). Cells were transfected using Exgen (Fermentas, Hanover, MD). Optimization experiments revealed that 180 pmol of siRNA was the minimum concentration for effective knockdown, and the knockdown lasted for at least 48 h (as determined by QPCR). To control for nonspecific siRNA effects such as the interferon response, Block-It, a fluorescein-labeled double stranded RNA oligo (Invitrogen, Carlsbad, CA), which does not share homology to any known sequence was used (referred to as scrambled). Thirty-six hours after transfection, cells were treated with either T 3 (50 ng/ml) or the HDAC inhibitor for 5 h. To ensure specificity of siRNA, the expression of all TRs was measured for each experiment (supplemental data).
QPCR
Primers are listed in supplemental Table 1 . All resulted in one amplicon (as determined by melt curve and gel electrophoresis analysis) and had an efficiency greater than 90%. As an internal control, ␤-actin was also amplified as described in (23) . A iCycler iQ multicolor real-time PCR detection system (Bio-Rad, Hercules, CA) was used with the following conditions per well: 0.5 l cDNA, 0.26 m of each primer, 0.2 mm deoxynucleotide triphosphates, Sybr green, and Taq polymerase in buffer [10 mm Tris-HCl (pH 9.0), 50 mm KCl, 1.4 mm MgCl 2 , 20 nm fluorescein] to a total volume of 25 l. Cycling was as follows: 3 min at 94 C followed by 30 -50 cycles of 10 sec at 94 C and 40 sec at 55 C (TRs and actin) or 57.6 C (D3). Each experimental group was run in duplicate or triplicate to ensure consistency. Results were calculated using the relative 2 -⌬⌬C t method, with ␤-actin as an internal control. Control (untreated) values were set at 1.
Determination of absolute TR mRNA levels
QPCR was used to determine the absolute mRNA levels for each TR subtype by comparison with standard curves generated in a similar way to RoséMeyer et al. (29) . Briefly, specific PCR product, generated as described for QPCR, was gel-purified and quantified (OD 260 ), and used to create a dilution series (standard curve). Ten separate liver cDNA samples were run alongside and their expression calculated based on the standard curve.
Statistics
The results (either raw or Ln transformed) were analyzed by one-way ANOVA followed by the Student Newman Keuls multiple comparison test (significance if P Ͻ 0.05).
Results

Identification of goldfish D3 sequences
The complete cDNA sequence for goldfish D3 was determined. The nucleic acid sequence contained a TGA codon, which would code for a selenocysteine (U). 3Ј RACE revealed two forms of goldfish D3 (named type a and type b). Both are identical with alternate 3Ј untranslated regions (UTRs) (supplemental Fig. 1 ). Type a has 1116 bp and type b has 1182 bp. A putative selenocysteine insertion sequence has been identified. Both end code for the same 274 amino acid protein, with a selenocysteine that shares high homology with other species (supplemental Table 3 ). The sequence has been deposited in the National Center for Biotechnology Information GenBank (accession no. D3a: EF190704 and D3b: EF190705).
Effect of T 3 on D3 expression, in vivo
Male and female fish showed very similar D3 expression in either control or T 3 -treated fish (data not shown). Therefore, sexes were combined for data analysis.
D3 expression was very low in untreated fish but increased dramatically in a dose-dependent manner after treatment with T 3 (Fig. 1) . After only 12 h after treatment, D3 expression was 740 times and more than 1000 times higher in fish treated with 25 and 250 ng of T 3 , compared with control. D3 expression remained significantly higher in fish treated with 250 ng of T 3 after 24 h. Whereas a pattern of increased D3 expression with dose of T 3 was apparent after 36 h, these changes were no longer significantly different from control levels.
D3 expression is up-regulated by T 3 in vitro and is repressed by histone deacetylase
T 3 up-regulated D3 expression in vitro in a dose-dependent manner ( Fig. 2A) . A dose of 5 ng/ml lead to a significant increase in D3 expression (Ͼ50-fold), whereas a dose of 50 ng/ml lead to an increase greater than 175-fold. The translation inhibitor, cycloheximide, had no effect, whereas the transcription inhibitor (actinomycin-D) inhibited the induction of D3 by T 3 (Fig. 2B) . In a separate experiment, treatment with T 3 (50 ng/ml) increased D3 expression by greater than 550-fold. Inhibiting HDAC increased basal levels of D3 by 189-fold, or 34% of T 3 -induced levels (Fig. 2C) . A combination of the HDAC inhibitor and T 3 had a synergistic effect, increasing D3 expression by 1182-fold (expected additive expression would be 741-fold higher than control).
TR␣-t expression is more abundant than the other subtypes
When investigating the basal absolute mRNA levels, it was found that TR␣-t had more than 3-fold the number of copies, compared with TR␣-1 and TR␣-2 (7.4, 2.0, and 2.2 ϫ 10 5 copies/g of total RNA, respectively) (see Fig.  6 , inset). TR␣-t expression was found to be twice as high as TR␤ (3.7 ϫ 10 5 copies/g RNA).
Knockdown of TR␣-1 reduces T 3 induction of D3 by half
siRNA targeting TR␣-1 decreased its expression to less than 5% of its control level, as determined by QPCR (Fig.  3) . Both TR␣-1 and D3 expression remained unchanged between control groups, groups treated with siRNA with for ␤-actin and with respect to control levels (mean Ϯ SEM). Different letters denote a significant difference (P Ͻ 0.05, n ϭ 4 -6/group).
no homology (scrambled), and siRNA against TR␣-1. T 3 up-regulated D3 expression by greater than 300-fold in either control cells or cells treated with scrambled siRNA. Only half of this response was observed in cells treated with siRNA against TR␣-1. siRNA against TR␣-1 did not effect the expression of the other TR subtypes (supplemental Fig. 2A ). siRNA against TR␣-2 was unsuccessful (data not shown).
Knockdown of TR␤ reduces T 3 induction of D3 by 85%
siRNA against TR␤ significantly reduced TR␤ expression by more than 95% (Fig. 4) . Scrambled siRNA had no significant effect on TR␤ or D3 expression. Treatment with T 3 significantly up-regulated D3 by more than 200-fold in both control cells and cells treated with scrambled siRNA. Whereas treatment with siRNA against TR␤ had no significant effect on the basal expression of D3, cells treated with it exhibited less than 15% of the T 3 -induced response when compared with control cells treated with scrambled siRNA. siRNA against TR␤ did not effect the expression of the other TR subtypes (supplemental Fig. 2B ).
siRNA against TR␣-t results in increased D3 expression and synergistically increases T 3 induction of D3
siRNA against TR␣-t significantly reduced TR␣-t expression (Fig. 5) . Scrambled siRNA had no effect on TR␣-t or D3 expression. Treatment with only T 3 induced D3 expression by about 500-fold. Treatment with siRNA against TR␣-t alone increased D3 expression by greater than 100-fold. This induction was still significantly lower than induction of control cells by T 3 . Treatment with siRNA against TR␣-t followed by T 3 up-regulated D3 by greater than 900-fold, which is almost twice that of T 3 treated control cells and greater than the additive effect of siRNA against TR␣-t and T 3 treatment alone. siRNA against TR␣-t did not affect the expression of the other TR subtypes (supplemental Fig. 2C ).
HDAC inhibition does not increase D3 expression to the same extent in cells treated with siRNA against TR␤
Treatment with the HDAC inhibitor alone resulted in an induction of D3 greater than 225-fold, whereas treatment with T 3 increased expression by greater than 700-fold (Fig.  6) . Treatment with siRNA against TR␤ followed by the HDAC inhibitor resulted in only a 8-fold increase, significantly lower than HDAC inhibitor treatment alone.
Knockdown of TR␣-t does not alter HDAC-induced D3 expression
Treatment with the HDAC inhibitor, T 3 , siRNA against TR␣-t, or combinations of these all lead to significant increases in D3 expression when compared with control levels (Fig. 7) . Treatment with the HDAC inhibitor alone resulted in a similar increase in D3 expression as cells treated with siRNA against TR␣-t followed by the HDAC inhibitor.
Knockdown of all known TR subtypes results in increased D3 expression
An siRNA targeting all known TR subtypes (siAll) resulted in at least a 75% knockdown (Fig. 8A) . This knockdown was sufficient to increase D3 levels by 154-fold, which is significantly higher than untreated control cells and cells treated with siRNA against TR␣-t (Fig. 8B) Different letters denote a significant difference (P Ͻ 0.05, n ϭ 4/group). Inset, Comparison of absolute mRNA levels for the TR subtypes in goldfish liver, as determined by QPCR. Expression was determined by comparison with a standard curve generated for each subtype. Results are expressed as transcript copy number (mean Ϯ SEM). Different letters denote a significant difference (P Ͻ 0.05, n ϭ 10/subtype).
followed by T 3 significantly up-regulated D3 over all groups except T 3 alone.
Discussion
The present study provides novel information on functional significance of TR subtypes, using goldfish as experimental model. Goldfish is a cyprinid species, which is an important comparative model as well as being significant in commercial aquaculture. Previous studies in goldfish provided information on four TR subtypes expressed in the liver (22) . In an effort to determine the functionality of the goldfish TRs, including a novel type lacking a LBD, we used a physiologically relevant bioassay approach. Based on information available on amphibian and other fish species (30 -32), we validated D3 response as a robust marker for T 3 action in goldfish. We identified the full cDNA sequence for two types of D3, identical in sequence except with alternative 3ЈUTRs. D3 sequence aligned well to other species and contained a TGA codon within the open reading frame (encoding a selenocysteine), lending support to its identity as deiodinase. Analysis of the 3ЈUTRs of D3 revealed a putative selenocysteine insertion sequence, which has been shown in other vertebrates to interact with the ribosome and permit a selenocysteine to be coded for, rather than a stop codon (for review see Ref. 33 ). An alternative 3ЈUTR for D3 has also been described in the rainbow trout (Oncorhynchus mykiss) (31). The primers used to determine D3 expression in this study were not able to distinguish between the two types of D3.
Consistent with our results for goldfish, hepatic D3 induction by T 3 has been reported in amphibians, Nile tilapia, and rainbow trout (30 -32, 34) . It is likely that the up-regulation observed in vivo is to a large extent due to direct action of T 3 because treatment of isolated goldfish hepatocytes in vitro also increased D3 expression, and a translation inhibitor (cycloheximide) had no effect on this induction. In related work, we found that the amplitude of D3 induction by T 3 was seasonally dependent on the reproductive stages of goldfish (our unpublished data), which may in part explain the observed variation in T 3 -induced response in different experiments. We demonstrated that as in mammals, in the absence of ligand, the TRs actively repress gene transcription, in part via HDAC activity, because an HDAC inhibitor also increases D3 expression.
The T 3 induction of D3 was diminished in cells treated with siRNA against either TR␣-1 or TR␤. It appears that TR␤ may play a larger role in the T 3 -mediated expression of D3 because when TR␤ was knocked down, T 3 induction of D3 was less than 25% of induced control cells, compared with about 50% when TR␣-1 was knocked down.
Interestingly, knocking down TR␣-t increased basal levels of D3 expression. This indicates that TR␣-t normally suppresses D3 transcription. Additionally, treatment of cells lacking TR␣-t with T 3 was found to increase D3 expression, further supporting our hypothesis that TR␣-t modulates normal thyroid activity. Previous studies on TRs lacking functional LBDs have been limited to mammalian TR␣-2. The dominant-negative activity of TR␣-2 has been demonstrated for rat (16, 17, 35) and human (36). However, these studies generally rely on overexpression of TR␣-2 and reporter assays. As such, the mechanism of action for TR␣-2 is not fully understood. Initial studies indicated that TR␣-2 competes with functional TRs for thyroid response elements (TREs) to exert its dominant-negative activity (37, 38). However, TR␣-2 retains its antagonistic activity, even when binding to TRE is prevented through mutation in the DNA-binding domain.
Here it is proposed that TR␣-2 may squelch other factors such as coactivating proteins (39). Additionally, it has been shown that the nature of TRE is important for the specificity of TR␣-2. If TR␣-2 heterodimerizes with the retinoid-X receptor, then it has the highest affinity for direct repeat response elements but very poor affinity for palindromic or inverted palindromic elements (40). Our study offers the first evidence that a TR lacking a LBD does antagonize normal thyroid activity, using primary cells with endogenous levels of all TRs using a physiologically relevant thyroidresponsive gene.
Whereas the dominant-negative activity of mammalian TR␣-2 is relatively small (41), truncation of its C terminus increased its affinity for DNA and its dominant-negative effects (37, 42). Because goldfish TR␣-t is also a truncated form of TR, it is possible that it too binds DNA with high affinity and may help explain the strong antagonistic effects observed. This proposed competition between TR␣-t and the full-length TRs must still be formally tested.
Based on the fact that an HDAC inhibitor increased D3 expression, it would be expected that if either TR␣-1 or TR␤ were knocked down, there would be a relief in active repression and a corresponding increase in D3 should be observed. However, this was not the case. D3 expression in cells treated with siRNA against either TR␣-1 or TR␤ remained at basal levels. There are at least three possible explanations for this: 1) the knockdown at the protein level was not sufficient to alleviate repression, 2) the other functional TR replaces the knocked-down TR and compensates for it, or 3) TR␣-t or TR␣-2 replaces the knocked-out TR and repress transcription. The first scenario is unlikely due to the large differences observed in D3 induction by T 3 between control cells and siRNA-treated cells (Figs. 3 and 4) . If TR␣-1 replaces the knocked-out TR␤ as scenario two suggests, then it would be expected that treatment of these cells with an HDAC inhibitor would alleviate repression to the same extent as control cells treated with the HDAC inhibitor. This was not the case; whereas there was a small induction of D3 by an HDAC inhibitor, its expression was significantly diminished, compared with control cells of the same treatment (Fig. 6 ). Furthermore, when TR␣-t was knocked down and treated with an HDAC inhibitor, D3 levels resembled the additive responses of TR␣-t knockdown alone and HDAC inhibition alone (Fig. 7) . Additionally, we found that TR␣-t mRNA levels are higher than either of the other subtypes (Fig. 6,  inset) , supporting a competition-based model. That leaves scenario 3 as the most likely: either TR␣-2 or TR␣-t replaces the knocked-down TR and represses D3 transcription in a HDAC-independent mechanism. In further support of an HDAC-independent mechanism, both TR␣-2 and TR␣-t lack the residues in the LBD of TRs normally associated with interacting with corepressors (43). In final support of this model, when all TRs are knocked down, there is a relief of repression and an increase in D3 transcript in the absence of ligand. This relief is significantly higher than the relief seen when TR␣-t alone is knocked down.
Taken together, we propose a model for the action of TRs in the goldfish liver including three possible configurations on the deiodinase promoter: TR␣-1 ϩ nuclear receptor dimerization partner, TR␤ ϩ nuclear receptor dimerization partner, or TR␣-truncated ϩ potential dimerization partner. In the absence of ligand, all three configurations repress transcription. TR␣-1 and TR␤ combinations repress via histone deacetylase. In the presence of ligand, corepressors are lost and coactivators are recruited to TR␣-1 and TR␤ configurations, leading to increased transcription, whereas the presence of TR␣-truncated continues to repress transcription of TR␣-1 and TR␤ mediated genes.
In addition to characterizing the goldfish deiodinase-3 gene and its regulation by T 3 , we used siRNA to knock down endogenous receptor levels, demonstrating clear changes in a cellular physiological response. Our results provide strong support for the hypothesis that a thyroid receptor molecule lacking the ligand binding domain plays a modulatory role in thyroid hormone-induced gene expression, using goldfish as an experimental model. These findings provide important insight into thyroid receptor biology in goldfish and a framework for the better understanding of thyroid receptor function in all vertebrates.
